Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Research Paper | Synapse

January 17, 2026RSC Advances0 citationsOpen Access

View Full Paper

HDAC inhibitors as anticancer drugs: chemical diversity, clinical trials, challenges and perspectives

AAA. AbdAllahAl-Azhar University

Key Points

The research aims to analyze clinical data on HDAC inhibitors to understand their effectiveness in cancer treatment.
Collected data from clinical trials involving HDAC inhibitors.
Compared various structural features of these compounds.
Analyzed the impact of those features on anticancer efficacy.
Identified key structural features that affect the efficacy of HDAC inhibitors.
Revealed limitations and challenges faced in clinical applications.
Suggested pathways for improving future cancer therapies using HDAC inhibitors.

Abstract

In an attempt to collect clinical data about HDAC inhibitors as very significant anticancer drugs, we aimed to compare data and reveal the impact of the structural features to help – develop better cancer therapy.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

A. AbdAllah (Thu,) studied this question.

synapsesocial.com/papers/696b25a9d2a12237a93490b2 https://doi.org/https://doi.org/10.1039/d5ra09034b